Data / Form D filings / Axion BioSystems, Inc.
Axion BioSystems, Inc.: Form D filings
Axion BioSystems, Inc., a biotechnology company in Atlanta, GA, filed 5 Form D notices with the SEC between 2009 and 2018. The latest, on October 5, 2018, reports $8 million sold of a $8 million offering to 31 investors.
Find out what Axion BioSystems, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1819 PEACHTREE ROAD NE, SUITE 350, Atlanta, GA, 30309
- Phone
- (404) 477-2557
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1458565
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 5, 2018 | New notice | $8,000,380 | $8,000,380 | $0 | 31 | Sep 27, 2018 | sec.gov |
| May 17, 2016 | New notice | $6,265,603 | $6,265,603 | $0 | 16 | May 11, 2016 | sec.gov |
| May 9, 2012 | New notice | $3,500,000 | $3,208,768 | $291,232 | 17 | Apr 27, 2012 | sec.gov |
| Jul 28, 2010 | New notice | $2,500,000 | $2,100,079 | $399,921 | 10 | Jul 16, 2010 | sec.gov |
| Apr 30, 2009 | New notice | $1,000,113 | $1,000,113 | $0 | 19 | Apr 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JAMES J. ROSS | Executive Officer, Director | |
| JAY J. TEICH | Director | |
| DAVID J. GIBSON | Director | |
| THOMAS J. O'BRIEN | Executive Officer, Director | |
| MICHELLE J. JARRARD | Director | |
| GLENN J. EPSTEIN | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Oct 1, 2018 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Axion BioSystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.